• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Predictors of Treatment Success for Multidrug Resistant Tuberculosis.

作者信息

Park Sang Won

机构信息

Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

出版信息

Infect Chemother. 2016 Dec;48(4):350-352. doi: 10.3947/ic.2016.48.4.350.

DOI:10.3947/ic.2016.48.4.350
PMID:28032490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5204019/
Abstract
摘要

相似文献

1
Predictors of Treatment Success for Multidrug Resistant Tuberculosis.耐多药结核病治疗成功的预测因素
Infect Chemother. 2016 Dec;48(4):350-352. doi: 10.3947/ic.2016.48.4.350.
2
Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.耐多药结核病痰培养转阴时间：预测因素及其与治疗结果的关系
Ann Intern Med. 2006 May 2;144(9):650-9. doi: 10.7326/0003-4819-144-9-200605020-00008.
3
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.肺耐多药结核病成功治疗结果的相关因素：一项个体患者数据荟萃分析。
Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1.
4
High Rates of Treatment Success in Pulmonary Multidrug-Resistant Tuberculosis by Individually Tailored Treatment Regimens.通过个体化定制治疗方案实现肺多药耐药结核病的高治疗成功率
Ann Am Thorac Soc. 2016 Aug;13(8):1271-8. doi: 10.1513/AnnalsATS.201512-845OC.
5
Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences.影响四个欧盟国家耐多药结核病管理的卫生系统因素——借鉴各国经验
BMC Public Health. 2017 Apr 19;17(1):334. doi: 10.1186/s12889-017-4216-9.
6
Prevalence of and risk factors for multidrug-resistant tuberculosis in Iran and its neighboring countries: systematic review and meta-analysis.伊朗及其邻国耐多药结核病的患病率和危险因素：系统评价与荟萃分析
Rev Soc Bras Med Trop. 2017 May-Jun;50(3):287-295. doi: 10.1590/0037-8682-0002-2017.
7
Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.预测埃塞俄比亚奥罗米亚地区耐多药结核病患者不良治疗结局的时间的因素。
PLoS One. 2019 Oct 30;14(10):e0224025. doi: 10.1371/journal.pone.0224025. eCollection 2019.
8
Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia.亚美尼亚和阿布哈兹耐多药结核病患者治疗中断模式对治疗成功的影响。
J Infect Dis. 2015 May 15;211(10):1607-15. doi: 10.1093/infdis/jiu551. Epub 2014 Oct 13.
9
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.秘鲁利马针对耐多药结核病的社区治疗。
N Engl J Med. 2003 Jan 9;348(2):119-28. doi: 10.1056/NEJMoa022928.
10
Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.耐多药结核病患者不良治疗结局的预测因素：一项回顾性队列研究。
Clin Microbiol Infect. 2018 Jun;24(6):612-617. doi: 10.1016/j.cmi.2017.09.012. Epub 2017 Sep 29.

引用本文的文献

1
Drug-resistant tuberculosis treatment success predictors in Namibia.纳米比亚耐多药结核病治疗成功的预测因素
JAC Antimicrob Resist. 2024 Dec 18;6(6):dlae211. doi: 10.1093/jacamr/dlae211. eCollection 2024 Dec.
2
Application of ultrasound multimodal imaging in the prediction of cervical tuberculous lymphadenitis rupture.超声多模态成像在预测颈淋巴结结核破裂中的应用。
Epidemiol Infect. 2024 Jan 30;152:e28. doi: 10.1017/S0950268824000153.
3
Percutaneous ultrasound-guided laser ablation for the treatment of cervical tuberculous lymphadenitis: a pilot study.经皮超声引导下激光消融治疗颈部结核性淋巴结炎：一项初步研究。
J Int Med Res. 2019 Apr;47(4):1512-1520. doi: 10.1177/0300060518821818. Epub 2019 Jan 11.

本文引用的文献

1
Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.耐多药肺结核痰培养转阴的相关因素
Int J Tuberc Lung Dis. 2016 Dec;20(12):1671-1676. doi: 10.5588/ijtld.16.0096.
2
Association between Body Mass Index and Sputum Culture Conversion among South Korean Patients with Multidrug Resistant Tuberculosis in a Tuberculosis Referral Hospital.一家结核病转诊医院中韩国耐多药结核病患者的体重指数与痰培养转阴之间的关联
Infect Chemother. 2016 Dec;48(4):317-323. doi: 10.3947/ic.2016.48.4.317. Epub 2016 Nov 21.
3
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.美国胸科学会/疾病控制与预防中心/美国传染病学会官方临床实践指南：药物敏感型肺结核的治疗
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.
4
Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.预测耐多药结核病患者痰培养转化的因素。
Int J Tuberc Lung Dis. 2012 Oct;16(10):1335-43. doi: 10.5588/ijtld.11.0811.
5
Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects.耐多药结核病患者在 DOTS 加强项目治疗后的不良结局预测因素。
Tuberculosis (Edinb). 2012 Sep;92(5):397-403. doi: 10.1016/j.tube.2012.06.003. Epub 2012 Jul 10.
6
Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.1994 - 2004年韩国抗结核药物耐药性趋势
Int J Tuberc Lung Dis. 2007 May;11(5):571-6.